Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $50,100 - $65,400
-1,200 Reduced 19.85%
4,845 $248,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $20,829 - $25,427
476 Added 8.55%
6,045 $254,000
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $3,431 - $4,251
75 Added 1.37%
5,569 $288,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $14,090 - $20,886
-341 Reduced 5.84%
5,494 $324,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $13,384 - $17,193
341 Added 6.21%
5,835 $251,000
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $2,980 - $3,376
-83 Reduced 1.49%
5,494 $215,000
Q1 2021

Apr 16, 2021

BUY
$33.49 - $37.77 $186,773 - $210,643
5,577 New
5,577 $202,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Financial Advisors, LLC Portfolio

Follow Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors, LLC with notifications on news.